List:
I've just joined and have browsed here with great interest. I offer below some information regarding a stem cell possibility in Colorado I recently came across. I haven't contacted them myself yet, but do intend to....
FWIW:
"Startup tries stem cells instead of joint replacements"
Denver Business Journal - by Bob Mook Denver Business Journal
by Jim J. Narcy
Regenerative Sciences Inc. has developed a stem-cell procedure that may be an alternative to replacement surgery -- or living with pain -- for those who suffer from knee, hip, elbow or shoulder problems.
The small, Westminster-based company recently launched a patent-pending process called Regenexx, which uses a patient's own stem cells to regenerate bone and cartilage.
In the simple "needle-in, needle-out" process, stem cells are drawn from a patient's marrow, cultivated in a laboratory for two to three weeks and injected back into the damaged area.
Dr. Chris Centeno -- founder, inventor and medical director of Regenerative Sciences -- said that unlike joint-replacement procedures that require weeks of physical therapy and pain medications, patients who go through the Regenexx procedure are back on their feet within one day.
Centeno said the idea behind the procedure came from years of personal frustration as a pain-management physician who deals with patients struggling with joint discomfort.
Regenexx didn't need approval from the Food and Drug Administration (FDA) because it's a medical procedure that doesn't involve medical products, Centeno said. He added that Regenerative Sciences has authored five reports that are being evaluated by peer-review boards.
The procedure, which is available through his Denver practice, has been used on about 50 people in the last two years.
Centeno said seven of 10 patients who went through the procedure reported increased function and dramatic reductions in pain. Centeno said the company is making alterations to the process to improve the results.
Costs for the procedure, which isn't covered by insurance, range from $5,000 to $7,000.
Regenerative Science wants to license the process throughout the country.
Centeno said the company is in negotiations with orthopedic surgery groups in South Florida and Texas. The company also plans to open several small laboratories throughout the country.
A specialist in musculoskeletal, spinal and neurologic injury, Centeno said health insurance companies eventually will cover Regenexx because the process is potentially much cheaper than surgical alternatives. Indeed, Centeno claims that procedures such as Regenexx are the wave of the future.
"You're going to see a lot less major surgeries and a lot more needle-based, low-intervention procedures," he said. Centeno said coronary bypass surgeries have declined 90 percent in the past 15 years. In recent years, doctors have used cardiac catheterization to get inside coronary arteries as an option to invasive surgery. "Everything is done with X-rays and stents," he said.
Regenerative Sciences plans to market Regenexx directly to consumers through advertising -- an approach that's become controversial in medical circles.
"As a doctor, I found it frustrating at first," Centeno said of advertising procedures and medication. "Oftentimes, patients knew more than I did. But I've come to embrace it."
Pixie Greenmeier, a nurse at The Children's Hospital, said the Regenexx procedure worked for her. Greenmeier, 47, underwent the procedure last January to repair a damaged knee. "I couldn't get up without grabbing onto something else," she said. "Now I can get up from a squat." Greenmeier said a grant covered the cost of her Regenexx procedure and her insurance company paid for the lab work.
Regenerative Sciences has raised about $1.7 million in financing since it was founded two years ago.
Besides Centeno, other owners include Dr. John Schultz (who practices anesthesiology and pain medicine in Greenwood Village), John Kisiday, assistant professor of equine orthopedic research at Colorado State University, and Matt Fulton, former CEO of Saint Anthony Hospitals.
All contents of this site ? American City Business Journals Inc. All rights reserved."
For What It's Worth...
I've just joined and have browsed here with great interest. I offer below some information regarding a stem cell possibility in Colorado I recently came across. I haven't contacted them myself yet, but do intend to....
FWIW:
"Startup tries stem cells instead of joint replacements"
Denver Business Journal - by Bob Mook Denver Business Journal
by Jim J. Narcy
Regenerative Sciences Inc. has developed a stem-cell procedure that may be an alternative to replacement surgery -- or living with pain -- for those who suffer from knee, hip, elbow or shoulder problems.
The small, Westminster-based company recently launched a patent-pending process called Regenexx, which uses a patient's own stem cells to regenerate bone and cartilage.
In the simple "needle-in, needle-out" process, stem cells are drawn from a patient's marrow, cultivated in a laboratory for two to three weeks and injected back into the damaged area.
Dr. Chris Centeno -- founder, inventor and medical director of Regenerative Sciences -- said that unlike joint-replacement procedures that require weeks of physical therapy and pain medications, patients who go through the Regenexx procedure are back on their feet within one day.
Centeno said the idea behind the procedure came from years of personal frustration as a pain-management physician who deals with patients struggling with joint discomfort.
Regenexx didn't need approval from the Food and Drug Administration (FDA) because it's a medical procedure that doesn't involve medical products, Centeno said. He added that Regenerative Sciences has authored five reports that are being evaluated by peer-review boards.
The procedure, which is available through his Denver practice, has been used on about 50 people in the last two years.
Centeno said seven of 10 patients who went through the procedure reported increased function and dramatic reductions in pain. Centeno said the company is making alterations to the process to improve the results.
Costs for the procedure, which isn't covered by insurance, range from $5,000 to $7,000.
Regenerative Science wants to license the process throughout the country.
Centeno said the company is in negotiations with orthopedic surgery groups in South Florida and Texas. The company also plans to open several small laboratories throughout the country.
A specialist in musculoskeletal, spinal and neurologic injury, Centeno said health insurance companies eventually will cover Regenexx because the process is potentially much cheaper than surgical alternatives. Indeed, Centeno claims that procedures such as Regenexx are the wave of the future.
"You're going to see a lot less major surgeries and a lot more needle-based, low-intervention procedures," he said. Centeno said coronary bypass surgeries have declined 90 percent in the past 15 years. In recent years, doctors have used cardiac catheterization to get inside coronary arteries as an option to invasive surgery. "Everything is done with X-rays and stents," he said.
Regenerative Sciences plans to market Regenexx directly to consumers through advertising -- an approach that's become controversial in medical circles.
"As a doctor, I found it frustrating at first," Centeno said of advertising procedures and medication. "Oftentimes, patients knew more than I did. But I've come to embrace it."
Pixie Greenmeier, a nurse at The Children's Hospital, said the Regenexx procedure worked for her. Greenmeier, 47, underwent the procedure last January to repair a damaged knee. "I couldn't get up without grabbing onto something else," she said. "Now I can get up from a squat." Greenmeier said a grant covered the cost of her Regenexx procedure and her insurance company paid for the lab work.
Regenerative Sciences has raised about $1.7 million in financing since it was founded two years ago.
Besides Centeno, other owners include Dr. John Schultz (who practices anesthesiology and pain medicine in Greenwood Village), John Kisiday, assistant professor of equine orthopedic research at Colorado State University, and Matt Fulton, former CEO of Saint Anthony Hospitals.
All contents of this site ? American City Business Journals Inc. All rights reserved."
For What It's Worth...
York was talking about a place in Colorado that may be doing some stem cell therapy, as i too am from Colorado and only 125 miles from Denver i will have to get their phone number and set up an appointment for a consultation. If ANYONE has any answers for me please call me at 970 522 4384 or 970 886 3993 in evening my name is Paul L. Thank You !